Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP

被引:216
作者
Pei, DQ [1 ]
机构
[1] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA
关键词
D O I
10.1074/jbc.274.13.8925
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new member of the membrane-type matrix metalloproteinase (MT-MMP) subfamily tentatively named MT5-MMP was isolated from mouse brain cDNA library. It is predicted to contain (i) a candidate signal sequence, (ii) a propeptide region with the highly conserved PRCGVPD sequence, (iii) a potential furin recognition motif RRRRNKR, (iv) a zinc-binding catalytic domain, (v) a hemopexin-like domain, (vi) a 24 residue hydrophobic domain as a potential transmembrane domain, and (vii) a short cytosolic domain. Reverse transcriptase-polymerase chain reaction analysis of its transcripts indicates that MT5-MMP is expressed in a brain-specific manner consistent with the origin of its EST clone from cerebellum. It is also highly expressed during embryonic development at stages day 11 and 15. Like other MT-MMPs, MT5-MMP specifically activates progelatinase A when co-expressed in Madin-Darby canine kidney cells. Its ability to activate progelatinase A is dependent on its proteolytic activity since a mutation converting Glu to Ala in the zinc binding motif HE(255)LGH renders MT5-MMP inactive against progelatinase A. In contrast to other MT-MMPs, MT5-MMP tends to shed from cell surface as soluble proteinases, thus offering flexibility as both a cell bound and soluble proteinase for extracellular matrix remodeling processes. Taken together, these properties serve to distinguish MT5-MMP as a versatile MT-MMP playing an important role in extracellular matrix remodeling events in the brain and during embryonic development.
引用
收藏
页码:8925 / 8932
页数:8
相关论文
共 39 条
[1]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[2]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[3]   Changing views of the role of matrix metalloproteinases in metastasis [J].
Chambers, AF ;
Matrisian, LM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) :1260-1270
[4]   MUTATION OF THE ACTIVE-SITE GLUTAMIC-ACID OF HUMAN GELATINASE-A - EFFECTS ON LATENCY, CATALYSIS, AND THE BINDING OF TISSUE INHIBITOR OF METALLOPROTEINASES-1 [J].
CRABBE, T ;
ZUCKER, S ;
COCKETT, MI ;
WILLENBROCK, F ;
TICKLE, S ;
OCONNELL, JP ;
SCOTHERN, JM ;
MURPHY, G ;
DOCHERTY, AJP .
BIOCHEMISTRY, 1994, 33 (21) :6684-6690
[5]   MT1-MMP on the cell surface causes focal degradation of gelatin films [J].
d'Ortho, MP ;
Stanton, H ;
Butler, M ;
Atkinson, SJ ;
Murphy, G ;
Hembry, RM .
FEBS LETTERS, 1998, 421 (02) :159-164
[6]   Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases [J].
d'Ortho, MP ;
Will, H ;
Atkinson, S ;
Butler, G ;
Messent, A ;
Gavrilovic, J ;
Smith, B ;
Timpl, R ;
Zardi, L ;
Murphy, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 250 (03) :751-757
[7]  
Gilles C, 1996, INT J CANCER, V65, P209
[8]  
Imai K, 1996, CANCER RES, V56, P2707
[9]   Expression of membrane-type matrix metalloproteinase-1 in human pancreatic adenocarcinomas [J].
Imamura, T ;
Ohshio, G ;
Mise, M ;
Harada, T ;
Suwa, H ;
Okada, N ;
Wang, ZH ;
Yoshitomi, S ;
Tanaka, T ;
Sato, H ;
Arii, S ;
Seiki, M ;
Imamura, M .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (02) :65-72
[10]   Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas [J].
Kitagawa, Y ;
Kunimi, K ;
Ito, H ;
Sato, H ;
Uchibayashi, T ;
Okada, Y ;
Seiki, M ;
Namiki, M .
JOURNAL OF UROLOGY, 1998, 160 (04) :1540-1545